Following the initial impact of the COVID-19 pandemic, the Japanese market for aortic repair devices will will expand at a modest rate, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent grafts. However, endovascular procedure volume growth will be hindered to some extent by unavailability of certain aortic stent graft brands that are available in other established markets but not in Japan.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aortic repair devices in Japan across a 10-year period.


The aortic repair device market will be affected by the COVID-19 crisis.

How will the COVID-19 outbreak affect the aortic repair device market? 

How quickly are procedure volumes expected to recover?

Aortic repair can be performed using endovascular, surgical, or hybrid procedures.

Which methods are preferred for which indications? 

To what extent are hybrid aortic repair procedures being performed for the aortic arch and thoracoabdominal indications in Japan?

How will the launch of new endovascular devices affect the market?

The penetration of endovascular treatment methods for aortic repair is growing.

What are the main drivers and limiters of growth in the Japanese endovascular aortic repair device market?

Which indication has seen the highest penetration of endovascular treatments?

For which indications will uptake of endovascular aortic repair procedures be limited and why?

MHLW reimbursement revisions will affect the Japanese aortic repair device market.

Which segments will be affected by the revisions?

What other factors will affect ASP trends?

Changes in the regulatory landscape will impact the Japanese aortic repair device market.

Which aortic repair devices were the first to be evaluated under HTAs?

How will increasing emphasis on cost-effectiveness data for Japanese reimbursement decisions impact the aortic repair device market?

Table of contents

  • Japan
    • Abstract
    • Executive Summary
      • COVID-19 Updates
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Average Currency Exchange Rates
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • COVID-19 Analysis
      • Market Impact
      • Guidance and Recommendations
      • Industry and Clinician Perspectives
      • Major Market Forecast Changes and Assumptions
      • Competitive Impact
    • Aortic Repair Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Technique (Procedures Only)
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Product Portfolio Management
        • Regulatory Environment
        • Product Recalls and Safety Issues
        • Reimbursement
        • Mergers, Acquisitions, and Partnerships
        • Clinical Data
        • Physician Training and Marketing
        • Distribution and Sales Network
      • Market Developments
    • Aortic Stent Graft Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Thoracic
        • Abdominal
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Physician Training and Marketing
    • Aortic Surgical Graft Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Thoracic
        • Abdominal
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Aortic Repair Accessory Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Siva Kumar Pulla, MBA (Pharm)

Siva Kumar Pulla is a research associate specializing in aortic repair devices within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate). Siva holds a Bachelor's degree in Pharmaceutical Sciences from Jawaharlal Nehru Technological University and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Hyderabad.


Related Reports

Aortic Repair Devices | Medtech 360 | Market Insights | Europe

The European market for aortic repair devices will expand at a modest rate, driven primarily by endovascular procedure volume growth and continue...

View Details

Aortic Repair Devices | Medtech 360 | Market Insights | United States

The US market for aortic repair devices will expand at a moderate rate, driven by increasing endovascular penetration in undertreated indications, in particular due to new device launches....

View Details

Aortic Repair Devices | Medtech 360 | Market Insights | Test

[Insert introduction sentence here—the introduction sentence should state why the market is significant (i.e., why clients should be interested in the market). Think of it as a tagli...

View Details

Aortic Repair Devices | Medtech 360 | Market Insights | Latin America (Supplemental)

The Latin American market for aortic repair devices will expand at a moderate rate through 2027, driven primarily by endovascular procedure volume growth and the continued developme...

View Details